Post-Mrna Vaccination SARS-CoV-2 IGG Concentrations and Surrogate Virus Neutralization Response Compared by HIV Status and Type of Vaccine: A Matched Case-Control Observational Study

2021 ◽  
Author(s):  
Matthew Spinelli ◽  
Michael J. Peluso ◽  
Kara L. Lynch ◽  
Cassandra A. Yun ◽  
David V. Glidden ◽  
...  
Keyword(s):  
Observational Study ◽  
Case Control ◽  
Virus Neutralization ◽  
Hiv Status ◽  
Matched Case ◽  
Neutralization Response

scholarly journals BCG protects against tuberculosis irrespective of HIV status: a matched case-control study in Mwanza, Tanzania: Table 1

Thorax ◽  
2012 ◽  
Vol 68 (3) ◽  
pp. 288-289 ◽  
Author(s):  
Daniel Faurholt-Jepsen ◽  
Nyagosya Range ◽  
George PrayGod ◽  
Kidola Jeremiah ◽  
Maria Faurholt-Jepsen ◽  
...  
Keyword(s):  
Case Control Study ◽  
Case Control ◽  
Hiv Status ◽  
Matched Case ◽  
Matched Case Control Study ◽  
Control Study

scholarly journals Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study

2021 ◽  
Author(s):  
Matthew A Spinelli ◽  
Michael J Peluso ◽  
Kara L Lynch ◽  
Cassandra Yun ◽  
David V Glidden ◽  
...  
Keyword(s):  
Neutralization Test ◽  
Virus Neutralization Test ◽  
Virus Neutralization ◽  
People Living With Hiv ◽  
Hiv Status ◽  
Test Response ◽  
Cell Counts ◽  
Matched Case ◽  
Living With Hiv ◽  
The Impact

Abstract Following SARS-CoV-2 mRNA vaccination, people living with HIV (PLWH) had lower surrogate virus neutralization test response (p=0.03) and a trend towards lower IgG response (p=0.08), particularly among those with lower CD4+T-cell counts and who received the BNT162b2 vaccine. Study of the impact of supplemental vaccine doses among PLWH is needed.

Sign in / Sign up

Export Citation Format

Share Document